These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 2599653

  • 1. Comparative efficacy of ciprofloxacin, azlocillin, imipenem/cilastatin and tobramycin in a model of experimental septicemia due to Pseudomonas aeruginosa in neutropenic mice.
    Ulrich E, Trautmann M, Krause B, Bauernfeind A, Hahn H.
    Infection; 1989; 17(5):311-5. PubMed ID: 2599653
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Therapeutic efficacy of cefpiramide-ciprofloxacin combination in experimental Pseudomonas infections in neutropenic mice.
    Fu KP, Hetzel N, Gregory FJ, Hung PP.
    J Antimicrob Chemother; 1987 Oct; 20(4):541-6. PubMed ID: 3680089
    [Abstract] [Full Text] [Related]

  • 6. Two neutropenic patients with multiple resistant Pseudomonas aeruginosa septicaemia treated with ciprofloxacin.
    Bendig JW, Kyle PW, Giangrande PL, Samson DM, Azadian BS.
    J R Soc Med; 1987 May; 80(5):316-7. PubMed ID: 3112380
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
    Rusnak MG, Drake TA, Hackbarth CJ, Sande MA.
    J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
    [Abstract] [Full Text] [Related]

  • 9. Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.
    Chin NX, Jules K, Neu HC.
    Eur J Clin Microbiol; 1986 Feb; 5(1):23-8. PubMed ID: 2938945
    [Abstract] [Full Text] [Related]

  • 10. The relative efficacies of tobramycin and ciprofloxacin against Pseudomonas aeruginosa in vitro and in normal and granulocytopenic mice.
    Hoogeterp JJ, Mattie H, Terporten P.
    Infection; 1988 Feb; 16(1):58-62. PubMed ID: 3129373
    [Abstract] [Full Text] [Related]

  • 11. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Norrby SR, Vandercam B, Louie T, Runde V, Norberg B, Anniko M, Andrien F, Baudrihaye M, Bow E, Burman LA.
    Scand J Infect Dis Suppl; 1987 Feb; 52():65-78. PubMed ID: 3331044
    [Abstract] [Full Text] [Related]

  • 12. Imipenem therapy of Pseudomonas aeruginosa bacteraemia in neutropenic rats.
    Johnson DE, Calia FM, Snyder MJ, Warren JW, Schimpff SC.
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():89-96. PubMed ID: 6583199
    [Abstract] [Full Text] [Related]

  • 13. The activity of ciprofloxacin against Pseudomonas aeruginosa in normal and granulocytopenic mice.
    Mattie H, Hoogeterp JJ, Terporten P.
    Pharm Weekbl Sci; 1987 Dec 11; 9 Suppl():S26-9. PubMed ID: 3125518
    [Abstract] [Full Text] [Related]

  • 14. Comparative efficacy of ciprofloxacin, ceftazidime and gentamicin, given alone or in combination, in a model of experimental septicemia due to Klebsiella pneumoniae in neutropenic mice.
    Trautmann M, Brückner O, Marre R, Hahn H.
    Infection; 1988 Dec 11; 16(1):49-53. PubMed ID: 3283038
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of azlocillin and ticarcillin in febrile neutropenic children with cancer: a comparative study.
    Kosmidis H, Varvoutsi M, Kafetzis D, Koupari G, Bouhoutsou D, Papadatos C.
    Chemioterapia; 1987 Jun 11; 6(2 Suppl):396-8. PubMed ID: 3334581
    [No Abstract] [Full Text] [Related]

  • 16. Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS, Pressler T, Jensen T, Rosdahl VT, Bentzon MW, Høiby N, Koch C.
    J Antimicrob Chemother; 1987 Jan 11; 19(1):101-7. PubMed ID: 3104273
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ciprofloxacin in the treatment of Pseudomonas infection in cystic fibrosis patients.
    Rubio TT, Shapiro C.
    J Antimicrob Chemother; 1986 Nov 11; 18 Suppl D():147-52. PubMed ID: 3100490
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of Pharmacokinetic/Pharmacodynamic Model-Based Optimized Combination Regimens against Multidrug-Resistant Pseudomonas aeruginosa in a Murine Thigh Infection Model by Using Humanized Dosing Schemes.
    Yadav R, Bulitta JB, Wang J, Nation RL, Landersdorfer CB.
    Antimicrob Agents Chemother; 2017 Dec 11; 61(12):. PubMed ID: 28993331
    [Abstract] [Full Text] [Related]

  • 20. Ciprofloxacin in experimental aortic valve endocarditis due to Pseudomonas aeruginosa.
    Bayer AS, Blomquist IK, Kim KS.
    J Antimicrob Chemother; 1986 May 11; 17(5):641-9. PubMed ID: 2941403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.